Cigna Investments Inc Ligand Pharmaceuticals Inc Transaction History

Cigna Investments Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$105.93 - $142.47 $302,006 - $406,181	-2,851 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$128.36 - $272.13 $73,550 - $155,930	-573 Reduced 16.73%	2,851 $387,000
Q3 2018 Nov 13, 2018	BUY	$211.18 - $274.49 $141,490 - $183,908	670 Added 24.33%	3,424 $564,000
Q2 2018 Aug 14, 2018	BUY	$150.77 - $207.98 $415,220 - $572,776	2,754 New	2,754 $570,000

257

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.96B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Cigna Investments Inc , based on Form 13F filings with the SEC.

Stay updated on Cigna Investments Inc with notifications on news.